Tenet Healthcare Corporation (NYSE:THC)’s Trend Up, Especially After Decreased Shorts

July 14, 2018 - By Anthony Romero

Tenet Healthcare Corporation (NYSE:THC) Logo

Investors sentiment decreased to 0.87 in Q1 2018. Its down 0.01, from 0.88 in 2017Q4. It is negative, as 25 investors sold Tenet Healthcare Corporation shares while 77 reduced holdings. 35 funds opened positions while 54 raised stakes. 109.21 million shares or 3.88% less from 113.62 million shares in 2017Q4 were reported.
394,100 are owned by Caspian L P. Millennium Mgmt Limited Liability Company holds 2.11 million shares. Saba Management L P holds 0.83% in Tenet Healthcare Corporation (NYSE:THC) or 613,605 shares. Laurion Cap Mgmt L P holds 22,757 shares or 0% of its portfolio. Cna Fincl Corporation has invested 0.05% of its portfolio in Tenet Healthcare Corporation (NYSE:THC). Columbus Circle holds 0.62% of its portfolio in Tenet Healthcare Corporation (NYSE:THC) for 1.25M shares. Great West Life Assurance Can has invested 0% in Tenet Healthcare Corporation (NYSE:THC). Jane Street Grp Ltd accumulated 18,727 shares or 0% of the stock. Phoenix Inv Adviser Lc invested in 1.18% or 27,500 shares. Estabrook Capital Mgmt has 30 shares for 0% of their portfolio. 500 are owned by Clearbridge Invests Limited Liability Co. 298 are owned by Envestnet Asset Management Inc. Quantbot Techs L P holds 0.04% or 16,900 shares. 134,164 were accumulated by Comml Bank Of America De. Amalgamated Bancshares has 11,664 shares.

The stock of Tenet Healthcare Corporation (NYSE:THC) registered a decrease of 6.8% in short interest. THC’s total short interest was 17.30 million shares in July as published by FINRA. Its down 6.8% from 18.57 million shares, reported previously. With 1.67 million shares average volume, it will take short sellers 10 days to cover their THC’s short positions. The short interest to Tenet Healthcare Corporation’s float is 22.94%.

It closed at $34.24 lastly. It is down 95.96% since July 14, 2017 and is uptrending. It has outperformed by 83.39% the S&P500.

Tenet Healthcare Corporation, together with its subsidiaries, operates as a diversified healthcare services company. The company has market cap of $3.49 billion. It operates in three divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. It currently has negative earnings. The companyÂ’s general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Tenet Healthcare Corporation (NYSE:THC) Ratings Coverage

Among 11 analysts covering Tenet Healthcare (NYSE:THC), 4 have Buy rating, 2 Sell and 5 Hold. Therefore 36% are positive. Tenet Healthcare had 16 analyst reports since January 23, 2018 according to SRatingsIntel. The rating was maintained by Wells Fargo with “Market Perform” on Wednesday, February 28. The rating was maintained by Morgan Stanley with “Underweight” on Wednesday, February 28. The firm has “Buy” rating given on Thursday, March 1 by Citigroup. The rating was maintained by Citigroup with “Buy” on Tuesday, May 8. As per Wednesday, May 2, the company rating was maintained by Morgan Stanley. Jefferies maintained the stock with “Buy” rating in Tuesday, February 27 report. The stock of Tenet Healthcare Corporation (NYSE:THC) earned “Outperform” rating by Raymond James on Wednesday, February 28. The firm has “Hold” rating by William Blair given on Tuesday, January 23. Mizuho maintained it with “Buy” rating and $3500 target in Wednesday, May 9 report. The rating was maintained by Mizuho on Thursday, March 22 with “Buy”.

More news for Tenet Healthcare Corporation (NYSE:THC) were recently published by: Seekingalpha.com, which released: “Oakmark Global Fund: Second Quarter 2018” on July 11, 2018. Benzinga.com‘s article titled: “Jefferies Downgrades Tenet As It Approaches Full Health” and published on June 29, 2018 is yet another important article.

Tenet Healthcare Corporation (NYSE:THC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.